Onconova Therapeutics Inc (OQ:ONTX)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ONTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 3rd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 21/20 May 19/20 Groopman Jerome Direct Ownership Common Stock P - Open market or private purchase 10,000 $0.363
May 20/20 May 19/20 Oler Abraham N. Direct Ownership Common Stock P - Open market or private purchase 15,000 $0.370
May 20/20 May 19/20 Guerin Mark Patrick Direct Ownership Common Stock P - Open market or private purchase 21,000 $0.360
May 20/20 May 19/20 Fruchtman Steven M Direct Ownership Common Stock P - Open market or private purchase 26,800 $0.368
Dec 26/19 Dec 20/19 Woodman Richard Charles Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 80,000  
Dec 26/19 Dec 20/19 Oler Abraham N. Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 60,000  
Dec 26/19 Dec 20/19 Fruchtman Steven M Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 200,000  
Dec 26/19 Dec 20/19 Guerin Mark Patrick Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 65,000  
Dec 26/19 Dec 20/19 Maniar Manoj Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 43,000  
Nov 27/19 Nov 25/19 Mehta Viren Direct Ownership Warrant (right to purchase) P - Open market or private purchase 250,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ONTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 3rd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 21/20 May 19/20 Groopman Jerome Direct Ownership Common Stock P - Open market or private purchase 10,000 $0.363
May 20/20 May 19/20 Oler Abraham N. Direct Ownership Common Stock P - Open market or private purchase 15,000 $0.370
May 20/20 May 19/20 Guerin Mark Patrick Direct Ownership Common Stock P - Open market or private purchase 21,000 $0.360
May 20/20 May 19/20 Fruchtman Steven M Direct Ownership Common Stock P - Open market or private purchase 26,800 $0.368
Dec 26/19 Dec 20/19 Woodman Richard Charles Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 80,000  
Dec 26/19 Dec 20/19 Oler Abraham N. Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 60,000  
Dec 26/19 Dec 20/19 Fruchtman Steven M Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 200,000  
Dec 26/19 Dec 20/19 Guerin Mark Patrick Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 65,000  
Dec 26/19 Dec 20/19 Maniar Manoj Direct Ownership Stock Option (right to purchase) A - Grant, award or other under Rule 16b-3(d) 43,000  
Nov 27/19 Nov 25/19 Mehta Viren Direct Ownership Warrant (right to purchase) P - Open market or private purchase 250,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ONTX

Competitors

Competitors with Recent Insider Filings
Allakos (OQ:ALLK)
ChemoCentryx (OQ:CCXI)
BioMarin Pharmaceutical (OQ:BMRN)